Abstract P62 is a synthetic peptide which corresponds to the glycine/alanine repeat sequence of Epstein-Barr virus nuclear antigen-i. It is the main epitope recognised by anti-rheumatoid arthritis nuclear antigen antibodies. It was shown previously that anti-P62 antibodies were raised fourfold in patients with rheumatoid arthritis compared with controls. To examine the possibility that this increase was due to cross reactive autoantibodies binding to P62, anti-P62 antibodies from serum samples taken from 10 patients with rheumatoid arthritis and five healthy controls were purified by affuiity chromatography. Immunoglobulin G anti-P62 antibodies purified from four of 10 serum samples from patients with rheumatoid arthritis also reacted with human epidermal keratin, denatured collagen type II and actin, but not with influenza antigens, as determined by enzyme linked immunosorbent assay (ELISA). Anti-P62 antibodies in serum samples from healthy controls and patients with rheumatoid arthritis reacted with epidermal keratin by immunoblotting. It is suggested that antibodies to the glycine/alanine repeat sequence of Epstein-Barr nuclear antigen-i recognise homologous epitopes on keratin, actin, and collagen. It is also possible that molecular mimicry between a major epitope on the Epstein-Barr virus and several autoantigens might contribute to the breakdown of tolerance and autoimmunity in patients with rheumatoid arthritis.
cross reactive autoantibodies binding to P62, anti-P62 antibodies from serum samples taken from 10 patients with rheumatoid arthritis and five healthy controls were purified by affuiity chromatography. Immunoglobulin G anti-P62 antibodies purified from four of 10 serum samples from patients with rheumatoid arthritis also reacted with human epidermal keratin, denatured collagen type II and actin, but not with influenza antigens, as determined by enzyme linked immunosorbent assay (ELISA). Anti-P62 antibodies in serum samples from healthy controls and patients with rheumatoid arthritis reacted with epidermal keratin by immunoblotting. It is suggested that antibodies to the glycine/alanine repeat sequence of Epstein-Barr nuclear antigen-i recognise homologous epitopes on keratin, actin, and collagen. It is also possible that molecular mimicry between a major epitope on the Epstein-Barr virus and several autoantigens might contribute to the breakdown of tolerance and autoimmunity in patients with rheumatoid arthritis. Accepted for publication 16 November 1990 The possibility that the Epstein-Barr virus might have a role in the pathogenesis of rheumatoid arthritis has been suggested by observations that patients with rheumatoid arthritis have high titres of antibodies to an Epstein-Barr virus associated antigen referred to as rheumatoid arthritis nuclear antigen (RANA) (reviewed in ref. 1). Recently we showed that a major epitope for RANA is represented by a synthetic peptide, P62, which corresponds to part of the glycine/alanine internal repeat sequence of the Epstein-Barr nuclear antigen-I (EBNA-1).2 Antibodies to P62 were increased fourfold in patients with rheumatoid arthritis, although levels of antibodies to other components of EBNA-1 were normal. 3 We suggest that the selectivity of this increased response to the glycine/alanine repeat sequences of EBNA-1 might be related to cross reactions with structural endogenous polypeptides such as cytokeratins and collagens.
In this study we used purified anti-P62 reaction with influenza A was observed with anti-P62 antibody purified from any serum sample. As a control for the possibility of nonspecific binding of IgG from some rheumatoid serum samples to affinity chromatography columns, purified antibodies to influenza were prepared from the four serum samples from patients with rheumatoid arthritis, which also contained the highest levels of cross reactive antibody to P62. The reactivity of the four preparations of anti-influenza antibodies with collagen was 1-5-3%, with keratin 1 5-2%, and with actin 1[5-5% (data not shown). Figure 3 shows that on immunoblotting, cross reactive anti-P62 antibodies purified from all four serum samples from patients with rheumatoid arthritis reacted with EBNA-1 and with purified epidermal keratin of molecular weight 56 kilodalton. Surprisingly, P62 antibodies from one control serum sample also reacted with keratin by blotting, even though there was no reaction with keratin by ELISA. There was no reaction with purified antiinfluenza antibodies or with the conjugate alone. We were unable to show reactivity with collagen polypeptides nor, in separate experiments, with actin using immunoblotting (data not shown).
Discussion
This study has shown that serum antibodies to P62, a peptide corresponding to a major epitope of rheumatoid arthritis nuclear antigen, and to the internal repeat sequence of EBNA-1 also react with actin, cytokeratin, and denatured type II collagen, as determined by ELISA. We suggest that these cross reactions may account not only for the increased levels of anti-P62 antibodies in patients with rheumatoid arthritis, but also for some of the autoantibodies which occur in the disease, such as those to actin, cytokeratin, and denatured collagen type II.'
The absence of nuclear staining on HEp-2 cells suggests that anti-P62 antibodies are not related to the antihistone antibodies which represent the antinuclear antibodies found in about 40% of patients with rheumatoid arthritis.'
These findings support our original hypothesis that the cross reactions between an Epstein-Barr virus encoded protein and a host protein could account for the increase of anti-RANA antibodies in patients with rheumatoid arthritis.8 They also consolidate our suggestion of a cross reaction between P62 and cytokeratin, which was shown by immunofluorescence and immunoblotting,3 and also confirm the findings of Birkenfield et al,9 who showed cross reactions with both cytokeratins and collagen by inhibition ELISA.
The design of our study has excluded several possible non-specific interactions between immunoglobulins and certain antigens as possible contributions to the cross reactions. P62, which is entirely composed of the neutral amino acids glycine and alanine, is unlikely to take part in non-specific charge-charge interactions. Evidence against the participation of the binding of the Fc component of IgG to the column or peptide, or other non-specific interactions, was provided by the absence of any anti-influenza or antinuclear antibody activity of the purified anti-P62 antibodies and the much lower levels of apparent cross reactivity of the purified anti-influenza antibodies. The same experiments confirm that our findings cannot be attributed to the theoretical possibility that the anti-P62 antibodies were copurified with rheumatoid factors, which in turn were bound to other IgG molecules with different specificities.
The cross reaction of anti-P62 antibodies with cytokeratin was confirmed by immunoblotting. The molecular basis of these cross reactions is probably reflected in the structure of P62 and the internal repeat sequence (IR3) of EBNA-1 from which it is derived. The IR3 region is entirely composed of the amino acids glycine and alanine with P62, having the sequence AGAGGGAGGAGAGGGAGGAGA. The high concentration of glycine (65% of the peptide) may explain the reaction of anti-P62 and anti-EBNA-1 with Sepharose conjugated to glycine observed previously.2 It may also account for the cross reaction with cytokeratins which contain long polyglycine sequences in addition to some glycine/alanine and glycine/serine repeats." Allowing for conservative substitutions, such as alanine/serine, type II collagen also shows homologies with P62 of up to six of eight amino acids (reviewed in ref. 12). Actin shows fewer similarities, although the sequence from position 11-18 GSGLCKAGF of human smooth muscle actin is identical in four of eight amino acids.'3 An additional factor which must be considered in apparent cross reactions with actin is that this protein is notoriously 'sticky' in antibody assays and is often identified as an extra polypeptide in immunoprecipitation systems. 4 The possibility that such an interaction occurred in the ELISA in our study is suggested by the finding that antibodies purified on the control (influenza) column showed the greatest reaction with actin-up to 5% of the original serum antibody. The fact that the binding of purified anti-P62 antibodies to actin was considerably higher (up to 33%) suggests that there was an additional binding component owing to a true cross reaction between actin and P62.
These data suggest that the autoimmune response in patients with rheumatoid arthritis may not be as heterogeneous as was originally thought. Possibly, anti-RANA, and some of the anticytokeratin, anticollagen and antiactin antibodies are, if not the same, closely related to each other by their reactivity with glycine rich repeat sequences. Whether the Epstein-Barr virus plays a part in the generation of such antibodies is still unknown, although it is possible that the presence of such a sequence in an immunogenic part of one of its major antigens might contribute to the breakdown of tolerance with the subsequent generation of antibodies to structural proteins. Such antibodies, particularly those against collagen, could play a role in the pathogenesis of rheumatoid arthritis. 
